Always looking ahead
Our Agenda 2030 gives clear direction to our more than 1,500 colleagues worldwide. It includes our three strategic pillars: Boost Stem Cell Donations, Improve Access to Transplantation, especially in countries where our support is needed, and Advance Research & Development to improve patient outcomes.
“I see DKMS expanding its reach even further, operating in multiple countries and regions across the globe with the aim to increase both the size and ethnic diversity of our database of potential donors. This way, we can provide even more patients with a second chance at life.” - Dr. Elke Neujahr, Global CEO of DKMS
“To achieve this goal we aim to have 20 million donors in our diverse pool by 2030, be facilitating 12,000 second chances at life per year, and have reached 200,000 second chances at life provided by DKMS donors.”